MR Vaccines Market to Surpass US$ 79.2 Million by 2028, Says Coherent Market Insights

SEATTLE, Feb. 15, 2022 /PRNewswire/ -- According to Coherent Market Insights, the MR vaccines market is estimated to be valued at US$ 55.7 million in 2021 and is expected to exhibit a CAGR of 2.1% over the forecast period (2021-2028).

Key Trends and Analysis of the MR Vaccines Market:

Key trends in the market include increasing incidence of measles and rubella (MR), ongoing clinical trials to develop safe MR vaccines, growing awareness about immunization services, and rising government initiatives to launch vaccine campaigns. These key trends are expected to aid in growth of the MR vaccines market.

Moreover, key players operating in the MR vaccines market are focusing on adoption of inorganic growth strategies such as partnerships with organizations such as WHO, UNICEF, and the GAVI Alliance, the global health partnership aims to increase access to immunization in poor countries to improve their immunization programs.

For instance, in June 2021, the Government of Kenya launched measles and rubella (MR) vaccination campaign in Kajiado County, with support of the World Health Organization, U.S. Centers for Disease Control and Prevention, UNICEF, and Gavi, the Vaccine Alliance. The campaign aimed to vaccinate about 3.9 million children with age group of 9 months to 5 years in 22 counties of Kenya.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4917

Key Market Takeaways:

The MR vaccines market is expected to exhibit a CAGR of 2.1% over the forecast period, owing to rise in ongoing clinical trials. For instance, in August 2020, a Phase II / III clinical trial of double viral vaccine for Measles and Rubella (MR) produced by Bio-Manguinhos / Fiocruz, a vaccine manufacturing company, was completed. The study was conducted in 11 months old children to assess the safety, immunogenicity, and reactogenicity of the MR vaccine.

Among vaccine brand, MR vaccine segment is estimated to account for the largest market share in 2021, owing to increasing focus on research and development activities to develop safe MR vaccines.

Key players operating in the MR vaccines market include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India, and Crucell Switzerland AG.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/4917 

Detailed Market Segmentation:

MR Vaccines Market, By Vaccine Brand:

• MR Vaccine
• MRBEV (BE LTD.)

MR Vaccines Market, By Distribution Channel:

• Public
• Private

MR Vaccines Market, By Region:

• North America
• By Country:
• U.S.
• Canada
• Europe
• By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• By Country:
• GCC Countries
• Israel
• South Africa
• Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/4917 

Find more related trending reports below:

Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Human Combination Vaccines Market, by Product Type (Inactivated Vaccine and Live Attenuated Vaccine), by Age Group (Children and Adults), by Combination Type (DTaP/IPV/Hep B, DTaP/Hib/IPV, MMR II, Hep B-Hib , and Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online Pharmacies) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2021- 2028

H1N1 Vaccines Market, by Vaccine Type (Inactivated Vaccine and Live Attenuated Vaccine), by Route of Administration (Injection and Intranasal), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg